山东鲁抗医药集团有限公司
 
中文版


    

   


R&D  

With an area of6000 m2, the Research Institute of Lukang

  Pharmaceutical is a high-tech development center approved by the provincial government. Total employees are 300 and most of them are engineers and senior engineers.
Lukang invests RMB30 million on R & D annually, which settle a massive base
  for the company to realize the products substitute of old generation, optimize the industry structure and participate in the new round competition in pharmaceutical market. Lukang Pharma possesses a whole system for new product development, including market investigation, product developing and designing and pilot production for new products. It sets up all types of research and development combination with colleges, universities and research institute home and abroad. The innovation of science and technology becomes strong actuating force for the market.
Rely on the advantages of fermentation technology for antibiotics and aim at
  international advanced technology, Lukang introduced, digested and absorbed the advanced scientific and research results with the combination of self research and development and by introducing foreign equipment and advanced technology to reconstruct traditional industry, which speeds up the products substitute from the old generation. The company is cultivating a lot of dominant products which meet the market demands. The three advantage of products innovation, chemical synthesis and fermentation technology comes into being.
Persist in the aim of developing eco-pharmaceuticals, Lukang develops high
  tech products which have potential market, such as enzyme, amino acid and drugs for immunity and its formulations. The structure advantage of the products will be enforced.